Sol Gel Technologies (SLGL) Osake Kurssi
Sol Gel Technologies Kurssi
Viimeisten 8 vuoden aikana Sol Gel Technologiesn liikevaihto kasvoi 80,2 % vuodessa ja ylsi 19,39 M USD:een. Sol Gel Technologiesn nettomarginaali −31,6 % on laskenut verrattuna 10,3 %:iin muutama vuosi sitten. Sol Gel Technologiesn 12 kuukauden konsensustavoitehinta on 110,00 USD, noin yli kurssia 60,9 %. 10 analyytikosta 9 suosittaa ostoa — kokonaiskonsensus on Osta.
Sol Gel Technologies osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Sol Gel Technologies liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Sol Gel Technologies -osakkeesta
The business model of Sol Gel Technologies Ltd is focused on developing and commercializing specialty pharmaceutical products. The company specializes in the research, development, and manufacturing of innovative formulations using its proprietary advanced silica-based delivery systems. Sol Gel Technologies aims to provide therapies that address unmet needs and improve the quality of patients' lives. With a strong emphasis on dermatology and dermatological conditions, the company strives to create effective and safe treatments for various skin diseases. Sol Gel Technologies' business model revolves around the discovery, development, and delivery of unique, advanced dermatology solutions.
Sol Gel Technologies Ltd is primarily active in the pharmaceutical and specialty chemicals industries.
The main competitors of Sol Gel Technologies Ltd in the market include major players such as Johnson & Johnson, L'Oréal, Procter & Gamble, Unilever, and Estée Lauder.
Sol Gel Technologies Ltd is a specialty pharmaceutical company that focuses on the development and commercialization of dermatological and topical generic drug products. Established in 1997, Sol Gel Technologies has a rich history of expertise in advanced topical drug delivery systems. The company utilizes its proprietary technology, known as microencapsulation, to enhance the solubility and efficacy of various drugs. Sol Gel Technologies aims to address unmet needs in the dermatology market and has developed a robust pipeline of products targeting various skin conditions. With a dedicated team and innovative approach, Sol Gel Technologies continues to contribute to the advancement of dermatological treatments.
Sol Gel Technologies Ltd has achieved several significant milestones. The company successfully completed its initial public offering in 2017, raising capital to support its advanced drug delivery solutions. In 2019, Sol Gel received FDA approval for its lead product, TWINRIX, a novel treatment for chronic hepatitis B virus infection. The company also obtained CE Marking for its innovative dermatological product, Epsolay, in 2020, allowing for its commercialization in Europe. Furthermore, Sol Gel entered into partnerships with renowned pharmaceutical companies, expanding its global reach and market presence. These accomplishments highlight Sol Gel Technologies Ltd's commitment to innovation, regulatory success, and strategic collaborations, positioning the company as a leader in the pharmaceutical industry.
Sol Gel Technologies Ltd is primarily present in the United States.
Sol Gel Technologies Ltd represents values such as innovation, integrity, and excellence. As a leading company in the specialty materials industry, Sol Gel Technologies emphasizes the development and commercialization of advanced silica-based products. Their corporate philosophy centers around delivering high-performance solutions, leveraging cutting-edge technology, and continuously improving customer satisfaction. With a focus on research and development, Sol Gel Technologies aims to address complex challenges in various industries, including healthcare, cosmetics, and industrial applications. By combining their expertise, commitment to quality, and customer-centric approach, Sol Gel Technologies is committed to creating value for their stakeholders and maintaining a strong market position in the industry.
Analyytikot asettavat tällä hetkellä Sol Gel Technologies-osakkeelle keskimääräisen tavoitehinnan 110,00 USD (mediaani: 110,00 USD), mikä merkitsee +60,9 % viimeisimpään hintaan verrattuna. Konsensus perustuu 10 analyytikkoarvioon.
10 analyytikkoa arvioi tällä hetkellä Sol Gel Technologies-osaketta: 9 suosittaa ostoa, 1 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat Sol Gel Technologies-yhtiöltä 1,02 M USD liikevaihtoa ja −7,76 USD osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Sol Gel Technologies-osake noteerataan hintaan 61,25 EUR (68,35 USD).
Sol Gel Technologies-osake (SLGL) on listattuna 2 pörssissä, muun muassa: NASDAQ (SLGL), Frankfurt (4SG.F).
Translate this as closely as possible to English. Sol Gel Technologies Ltd is an emerging company that develops and manufactures state-of-the-art materials for a variety of applications. The company's business model focuses on three main areas: the pharmaceutical, cosmetic, and industrial sectors. In the field of pharmaceuticals, Sol Gel Technologies Ltd develops and produces innovative active ingredients for topical use in skin conditions such as acne, rosacea, and psoriasis. Their patented formulation technology allows for the incorporation of active ingredients into a gel matrix to ensure high stability and reliable release of the active ingredients. Their products are successfully used in the skincare industry, providing a solution for skin conditions experienced by millions of people worldwide. In the cosmetic field, Sol Gel Technologies Ltd produces the innovative brand "SOL", motivated by the idea of achieving the best results through the combination of science and nature. Their product line includes a wide range of sunscreens with promising sunscreen formulas to protect against UV rays and other environmental damages. The SOL brand is available in markets in Europe and the USA and has gained increasing consumer trust due to its natural ingredients and high-quality standards. Lastly, Sol Gel Technologies Ltd also offers innovative industrial solutions. They develop specialized materials to enhance the performance of automotive and aerospace applications, such as advanced coatings to increase surface durability, nanoparticles for lubricants and corrosion protection, and waterproof coatings for electronic devices. Their focus on research and development allows them to develop customized solutions for their customers, utilizing modern technologies. The core of Sol Gel Technologies' business model is to deliver innovative solutions for a variety of markets through creative use of materials science. The company places great emphasis on research and development and strives to expand the understanding of materials science through the development of innovative technologies. With their patented gel matrix technology and the use of advanced materials, they are able to offer products and solutions that provide the highest effectiveness and safety. Overall, Sol Gel Technologies Ltd is a dedicated company that inspires its customers through creativity, quality, and innovation. By developing products and materials for a wide range of applications, they stay at the forefront of technology and guarantee their customers the highest quality and efficiency. Answer: Sol Gel Technologies Ltd is an innovative company that develops and manufactures advanced materials for various industries, including pharmaceuticals, cosmetics, and industrial applications. They specialize in creating effective solutions for skin conditions, sun protection products, as well as materials for automotive and aerospace industries. The company prioritizes research and development to deliver high-quality and safe products.
odotettu liikevaihto Sol Gel Technologies on 1,02 M USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Sol Gel Technologies on −21,63 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Sol Gel Technologies:n hinta-voitto-suhde (P/E) on tällä hetkellä −8,81. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Sol Gel Technologies-osakkeen arvostusta.
Sol Gel Technologies:n hinta-myynti-suhde (P/S) on tällä hetkellä 185,96. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Sol Gel Technologies-osakkeen arvostuskennuslukuna.
Sol Gel Technologies:n Eulpool-laatuscore on 3/10.
Sol Gel Technologies:n ISIN on IL0011417206. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Sol Gel Technologies:n WKN on A2JDHD. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Sol Gel Technologies:n ticker on SLGL. Tämä pörssinoteeraus käytetään Sol Gel Technologies-osakkeiden kauppaan pörssissä.
Sol Gel Technologies osake
Sol Gel Technologies vertaisryhmä
Sol Gel Technologies Ticker
Sol Gel Technologies FIGI
Kaikki tunnusluvut ja syvällinen analyysi Sol Gel Technologies:sta
Meidän osakeanalyysimme Sol Gel Technologies-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Sol Gel Technologies:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: